Q1’s Industry Insights round up all the latest regulatory news
Articles filtered by tag
Clinical Trials News and Regulations
Our latest Industry Update finishes the year focusing on COVID-19 & BREXIT
MHRA Post-Transition Period Information
All the information you need on the BREXIT transition direct from our Regulatory Team
MHRA Submissions – The UK submissions portal from 01 January 2021
Find out about the MHRA Submissions Portal by talking to our team.
Clinical Trials News from around the Globe
All the latest regulatory updates compiled for you by S-cubed.
EMA Publishes Updated Guidance on Nitrosamines Impurities
Latest news from EMA regarding nitrosamines
Clinical Development Practices & Regulations
Our latest Industry Update for Q2 covers the latest regulatory information around COVID-19 and much more.
COVID-19: European Medicines Agency Updates
Latest updates from EMA in response to the COVID-19 pandemic.
Nitrosamine Risk Evaluation for Marketing Authorisation Holders
The deadline for Nitrosamine Risk Evaluation is looming. Are you ready?
Clinical Trial Regulation, ICH E6(R2) & Brexit
Our first Industry Update of 2020 focuses on Clinical Trial Regulation, Brexit and the latest from FDA & EMA.
MAH Nitrosamine Risk Evaluation update – 1 month to go
With just one month to go, have you completed your risk evaluations? Make sure you are ready!
Nitrosamine MAH Risk Assessment – Two Months to Go
Two Months to Go – Human medicinal product licences to be reviewed for the presence of Nitrosamine Impurities